Exact Mass: 471.1592552

Exact Mass Matches: 471.1592552

Found 49 metabolites which its exact mass value is equals to given mass value 471.1592552, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

10-Formyldihydrofolate

(2S)-2-[(4-{N-[(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl]formamido}phenyl)formamido]pentanedioic acid

C20H21N7O7 (471.1502396)


10-Formyldihydrofolate is a folate compound that has not been found as a component of intracellular folates in normal tissues but has been identified in the cytosol of methotrexate (MTX)-treated MCF-7 breast cancer cells and normal human myeloid precursor cells. The origin of 10-formyldihydrofolate remains an enigma. Its appearance only in the extracts from MTX-treated cells is not consistent with a simple oxidation of lO-formyl-H4folate during the extraction procedure. This, however, does not exclude the occurrence of spontaneous oxidation of 10-formyl-H4folate within the intact cells prior to the folate extraction. (PMID: 3366769) [HMDB] 10-formyldihydrofolate is a folate compound that has not been found as a component of intracellular folates in normal tissues but has been identified in the cytosol of methotrexate (MTX)-treated MCF-7 breast cancer cells and normal human myeloid precursor cells. The origin of 10-formyldihydrofolate remains an enigma. Its appearance only in the extracts from MTX-treated cells is not consistent with a simple oxidation of lO-formyl-H4folate during the extraction procedure. This, however, does not exclude the occurrence of spontaneous oxidation of 10-formyl-H4folate within the intact cells prior to the folate extraction. (PMID: 3366769).

   

Norfluoxetine glucuronide

(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)oxane-2-carboxylic acid

C22H24F3NO7 (471.150479)


Norfluoxetine glucuronide is a metabolite of fluoxetine. Fluoxetine (also known by the tradenames Prozac, Sarafem, Fontex, among others) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. Fluoxetine was first documented in 1974 by scientists from Eli Lilly and Company. It was presented to the U.S. Food and Drug Administration in February 1977, with Eli Lilly receiving final approval to market the drug in December 1987. Fluoxetine went off-patent in August 2001 (Wikipedia).

   

5-formyl-tetrahydrofolate

4-Carboxy-4-[(4-{[(5-formyl-2-imino-4-oxido-1,2,5,6,7,8-hexahydropteridin-6-yl)methyl]amino}phenyl)formamido]butanoic acid

C20H21N7O7 (471.1502396)


5-formyl-tetrahydrofolate is a member of the class of compounds known as tetrahydrofolic acids. Tetrahydrofolic acids are heterocyclic compounds based on the 5,6,7,8-tetrahydropteroic acid skeleton conjugated with at least one L-glutamic acid unit. 5-formyl-tetrahydrofolate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 5-formyl-tetrahydrofolate can be found in a number of food items such as fennel, greenthread tea, orange mint, and coriander, which makes 5-formyl-tetrahydrofolate a potential biomarker for the consumption of these food products.

   
   

CAY10650

CAY10650

C28H25NO6 (471.168179)


CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion[1][2].

   

b-D-Glucopyranuronic acid

b-D-Glucopyranuronic acid

C22H24F3NO7 (471.150479)


   

Dorsomorphin 2HCl

Dorsomorphin 2HCl

C24H27Cl2N5O (471.1592552)


Dorsomorphin (Compound C) dihydrochloride is a potent, selective and ATP-competitive AMPK inhibitor, with a Ki of 109 nM. Dorsomorphin dihydrochloride inhibits BMP pathway by targeting the type I receptors ALK2, ALK3, and ALK6. Dorsomorphin dihydrochloride can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599).

   

Quinacrine dihydrochloride

Quinacrine (dihydrochloride)

C23H32Cl3N3O (471.1610832)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   
   
   

N-[1-[4-(2-methoxyphenyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]benzenesulfonamide

N-[1-[4-(2-methoxyphenyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]benzenesulfonamide

C24H29N3O3S2 (471.16502440000005)


   

4-(2-Hydroxybenzylamino)-N-(3-(4-fluorophenoxy)phenyl)piperidine-1-sulfonamide

4-(2-Hydroxybenzylamino)-N-(3-(4-fluorophenoxy)phenyl)piperidine-1-sulfonamide

C24H26FN3O4S (471.1627968000001)


   

N-((1R,2S)-2-(5-chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide

N-((1R,2S)-2-(5-chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide

C23H26ClN5O2S (471.1495646000001)


   

N-((1R,2R)-2-(5-Chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-C]pyridine-2-carboxamide

N-((1R,2R)-2-(5-Chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-C]pyridine-2-carboxamide

C23H26ClN5O2S (471.1495646000001)


   

2-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-YL)ethyl]-4-(4-ethoxy-1,1-biphenyl-4-YL)-4-oxobutanoic acid

2-[2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-YL)ethyl]-4-(4-ethoxy-1,1-biphenyl-4-YL)-4-oxobutanoic acid

C28H25NO6 (471.168179)


   

Citrovorum factor

Citrovorum factor

C20H21N7O7-2 (471.1502396)


D020011 - Protective Agents > D000931 - Antidotes D018977 - Micronutrients > D014815 - Vitamins

   

10-Formyltetrahydrofolate dianion

10-Formyltetrahydrofolate dianion

C20H21N7O7-2 (471.1502396)


   

5-formyl-tetrahydrofolate

5-formyl-tetrahydrofolate

C20H21N7O7-2 (471.1502396)


   

5-Formyltetrahydrofolate(2-)

5-Formyltetrahydrofolate(2-)

C20H21N7O7-2 (471.1502396)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

alpha-Neup5Ac-(2->6)-beta-D-Galp

alpha-Neup5Ac-(2->6)-beta-D-Galp

C17H29NO14 (471.1587974)


alpha-Neup5Ac-(2->6)-D-Galp in which the anomeric configuration of the reducing-end D-galactose residue is beta.

   

alpha-Neu5Ac-(2->3)-D-Gal

alpha-Neu5Ac-(2->3)-D-Gal

C17H29NO14 (471.1587974)


An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position

   

alpha-Neup5Ac-(2->6)-D-Galp

alpha-Neup5Ac-(2->6)-D-Galp

C17H29NO14 (471.1587974)


An amino disaccharide consisting of D-galactose having an alpha-N-acetylneuraminyl residue attached at the 6-position

   

3-furanyl-[4-[3-(4-methoxyphenyl)-4-(trifluoromethyl)-2H-pyrazolo[3,4-b]pyridin-6-yl]-1-piperazinyl]methanone

3-furanyl-[4-[3-(4-methoxyphenyl)-4-(trifluoromethyl)-2H-pyrazolo[3,4-b]pyridin-6-yl]-1-piperazinyl]methanone

C23H20F3N5O3 (471.1518166000001)


   

3-[2,4-dioxo-1-[(4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-quinazolinyl]-N-(2-furanylmethyl)propanamide

3-[2,4-dioxo-1-[(4-oxo-2-pyrido[1,2-a]pyrimidinyl)methyl]-3-quinazolinyl]-N-(2-furanylmethyl)propanamide

C25H21N5O5 (471.15426160000004)


   

3-O-{5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl}-alpha-D-galactopyranose

3-O-{5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl}-alpha-D-galactopyranose

C17H29NO14 (471.1587974)


   

(6s)-10-Formyltetrahydrofolate

(6s)-10-Formyltetrahydrofolate

C20H21N7O7-2 (471.1502396)


   

3-O-(5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranonosyl)-D-galactopyranose

3-O-(5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranonosyl)-D-galactopyranose

C17H29NO14 (471.1587974)


   
   
   
   

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-beta-D-galacto-hexopyranose

C17H29NO14 (471.1587974)


   

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-alpha-D-galacto-hexopyranose

5-acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosylonic acid-(2->3)-alpha-D-galacto-hexopyranose

C17H29NO14 (471.1587974)


   

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-methyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1,3-dihydroxy-2-methyl-1-phenylpropan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C20H29N3O8S (471.16752740000004)


   

(2R,4S,5R,6R)-5-acetamido-2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

(2R,4S,5R,6R)-5-acetamido-2-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

C17H29NO14 (471.1587974)


   

10-Formyldihydrofolate

10-Formyldihydrofolate

C20H21N7O7 (471.1502396)


   

(6S)-5-formyltetrahydrofolate(2-)

(6S)-5-formyltetrahydrofolate(2-)

C20H21N7O7 (471.1502396)


A dicarboxylic acid dianion arising from deprotonation of both carboxylic acid groups of (6S)-5-formyltetrahydrofolic acid.

   
   

(6S)-10-formyltetrahydrofolate(2-)

(6S)-10-formyltetrahydrofolate(2-)

C20H21N7O7 (471.1502396)


   

5-Formyltetrahydrofolate(2-)

5-Formyltetrahydrofolate(2-)

C20H21N7O7 (471.1502396)


A dicarboxylic acid dianion obtained by deprotonation of the carboxy groups of 5-formyltetrahydrofolic acid.

   

10-Formyltetrahydrofolic acid

10-Formyltetrahydrofolic acid

C20H21N7O7 (471.1502396)


A form of tetrahydrofolate that acts as a donor of formyl groups in anabolism. In these reactions 10-formyltetrahydrofolic acid is used as a substrate in formyltransferase reactions, which is important in purine biosynthesis.

   

alpha-Neup5Ac-(2->3)-beta-D-Galp

alpha-Neup5Ac-(2->3)-beta-D-Galp

C17H29NO14 (471.1587974)


An amino disaccharide consisting of beta-D-galactose having an alpha-N-acetylneuraminyl residue attached at the 3-position

   

(6R)-10-formyltetrahydrofolate(2-)

(6R)-10-formyltetrahydrofolate(2-)

C20H21N7O7 (471.1502396)


   

alpha-Neup5Ac-(2->3)-alpha-D-GalpNAc

alpha-Neup5Ac-(2->3)-alpha-D-GalpNAc

C17H29NO14 (471.1587974)


An amino disaccharide comprised of an N-acetyl-alpha-neuraminyl residue linked (2->3) to N-acetyl-alpha-D-galactosamine

   

10-formyltetrahydrofolate(2-)

10-formyltetrahydrofolate(2-)

C20H21N7O7 (471.1502396)


Dianion of 10-formyltetrahydrofolic acid arising from deprotonation of both carboxylic acid functions.

   
   

(15r,16r,17s,18r,20s)-2,15,16-trihydroxy-8-[(1r)-1-hydroxypropyl]-17-methoxy-6,18-dimethyl-19,21-dioxa-7-azapentacyclo[12.7.0.0³,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(14),2,4(9),5,7,11-hexaene-10,13-dione

(15r,16r,17s,18r,20s)-2,15,16-trihydroxy-8-[(1r)-1-hydroxypropyl]-17-methoxy-6,18-dimethyl-19,21-dioxa-7-azapentacyclo[12.7.0.0³,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(14),2,4(9),5,7,11-hexaene-10,13-dione

C24H25NO9 (471.152924)


   

2-{[1-(2h-1,3-benzodioxol-5-ylmethyl)-6-methoxyisoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(2h-1,3-benzodioxol-5-ylmethyl)-6-methoxyisoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C24H25NO9 (471.152924)


   

(2s,3r,4s,5s,6r)-2-{[1-(2h-1,3-benzodioxol-5-ylmethyl)-6-methoxyisoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{[1-(2h-1,3-benzodioxol-5-ylmethyl)-6-methoxyisoquinolin-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C24H25NO9 (471.152924)